Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Differentiated Thyroid Cancer × vandetanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Lung Neoplasms 2 Thyroid Neoplasms 1 Neoplasm Metastasis 1 Familial medullary thyroid carcinoma 1 Differentiated Thyroid Cancer 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Adenocarcinoma 1

Interventions

Thyrotropin Alfa 2 vandetanib 1 donafenib 1 apatinib 1 Iodine-131 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876784 2024-07-23

VERIFY

Sanofi

Phase 3 Completed

238 enrolled 12 charts

EndocrineHead & Neck

Differentiated Thyroid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡